Skip to main content
Premium Trial:

Request an Annual Quote

Cellzome Snags More Than $3.1M in Grants for EU-, UK-Sponsored Research Initiatives

Premium

Proteomics firm Cellzome said this week it has won more than €2.3 million ($3.1 million) in grants funding its participation in three separate research projects.

The funding supports Cellzome’s work in: Blueprint, an EU-funded effort to analyze the epigenome of the hematopoietic system; Orchid, an EU-funded project in which Cellzome will work under the direction of drugmaker GlaxoSmithKline to identify new drug targets in tuberculosis; and a stem cell characterization project the company has undertaken in collaboration with Pfizer, the University of Sheffield, and the stem cell firm Plasticell (see story this issue).

The company will receive €1.2 million for its work on the Blueprint project, €1.1 million for its stem cell research, and an undisclosed amount for its participation in the Orchid project, which, according to Cellzome chief scientific officer David Simmons, will be centered at GSK’s “Open Lab” in Tres Cantos, Spain.

Cellzome will be using its Episphere and Kinobeads chemoproteomics platforms in these projects, as well as mass spec-based proteome-wide screening methods.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.